These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9932943)

  • 1. Increased therapeutic efficacy with rt-PA and anti-CD18 antibody treatment of stroke in the rat.
    Zhang RL; Zhang ZG; Chopp M
    Neurology; 1999 Jan; 52(2):273-9. PubMed ID: 9932943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke.
    Zhang L; Zhang ZG; Zhang RL; Lu M; Krams M; Chopp M
    Stroke; 2003 Jul; 34(7):1790-5. PubMed ID: 12805500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
    Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
    J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolysis with tissue plasminogen activator alters adhesion molecule expression in the ischemic rat brain.
    Zhang RL; Zhang ZG; Chopp M; Zivin JA
    Stroke; 1999 Mar; 30(3):624-9. PubMed ID: 10066862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection with NBQX and thrombolysis with rt-PA in rat embolic stroke.
    Overgaard K; Sereghy T; Pedersen H; Boysen G
    Neurol Res; 1993 Oct; 15(5):344-9. PubMed ID: 7905610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postischemic treatment (2-4 h) with anti-CD11b and anti-CD18 monoclonal antibodies are neuroprotective after transient (2 h) focal cerebral ischemia in the rat.
    Zhang ZG; Chopp M; Tang WX; Jiang N; Zhang RL
    Brain Res; 1995 Nov; 698(1-2):79-85. PubMed ID: 8581506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced brain infarct volume and improved neurological outcome by inhibition of the NR2B subunit of NMDA receptors by using CP101,606-27 alone and in combination with rt-PA in a thromboembolic stroke model in rats.
    Yang Y; Li Q; Yang T; Hussain M; Shuaib A
    J Neurosurg; 2003 Feb; 98(2):397-403. PubMed ID: 12593629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early (1 h) administration of tissue plasminogen activator reduces infarct volume without increasing hemorrhagic transformation after focal cerebral embolization in rats.
    Zhang RL; Chopp M; Zhang ZG; Divine G
    J Neurol Sci; 1998 Sep; 160(1):1-8. PubMed ID: 9804110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postischemic (6-Hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia.
    Zhang L; Zhang ZG; Zhang RL; Lu M; Adams J; Elliott PJ; Chopp M
    Stroke; 2001 Dec; 32(12):2926-31. PubMed ID: 11739997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoprotein IIb/IIIa antagonist, murine 7E3 F(ab') 2, and tissue plasminogen activator in focal ischemia: evaluation of efficacy and risk of hemorrhage with combination therapy.
    Shuaib A; Yang Y; Nakada MT; Li Q; Yang T
    J Cereb Blood Flow Metab; 2002 Feb; 22(2):215-22. PubMed ID: 11823719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study.
    Baran KW; Nguyen M; McKendall GR; Lambrew CT; Dykstra G; Palmeri ST; Gibbons RJ; Borzak S; Sobel BE; Gourlay SG; Rundle AC; Gibson CM; Barron HV;
    Circulation; 2001 Dec; 104(23):2778-83. PubMed ID: 11733394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response of rt-PA and its combination with aspirin in a rat embolic stroke model.
    Overgaard K; Sereghy T; Pedersen H; Boysen G
    Neuroreport; 1992 Oct; 3(10):925-8. PubMed ID: 1421100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke.
    Zhang L; Zhang ZG; Zhang R; Morris D; Lu M; Coller BS; Chopp M
    Circulation; 2003 Jun; 107(22):2837-43. PubMed ID: 12756151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new rat model of thrombotic focal cerebral ischemia.
    Zhang Z; Zhang RL; Jiang Q; Raman SB; Cantwell L; Chopp M
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):123-35. PubMed ID: 9040491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats.
    Murakami K; Suzuki M; Suzuki N; Hamajo K; Tsukamoto T; Shimojo M
    Brain Res; 2013 Aug; 1526():84-93. PubMed ID: 23791950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?].
    Kirchhof K; Sikinger M; Welzel T; Zoubaa S; Sartor K
    Rofo; 2004 Jan; 176(1):98-105. PubMed ID: 14712413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin Gallate Extends the Therapeutic Window of Recombinant Tissue Plasminogen Activator Treatment in Ischemic Rats.
    You YP
    J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):990-7. PubMed ID: 26851971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of delayed thrombolysis with rt-PA in a rat embolic stroke model.
    Overgaard K; Sereghy T; Pedersen H; Boysen G
    J Cereb Blood Flow Metab; 1994 May; 14(3):472-7. PubMed ID: 8163589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of albumin prior to delayed thrombolysis reduces brain edema and blood brain barrier permeability in an embolic stroke model.
    Lu HT; Zhao JG; Li MH; Li YD
    Brain Res; 2012 Feb; 1438():75-84. PubMed ID: 22227456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of combined treatment of embolic stroke in rat with r-tPA and a GPIIb/IIIa inhibitor.
    Ding G; Jiang Q; Zhang L; Zhang ZG; Li L; Knight RA; Ewing JR; Wang Y; Chopp M
    J Cereb Blood Flow Metab; 2005 Jan; 25(1):87-97. PubMed ID: 15678115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.